The Preferred Stock Of Chimera Investment Remains Highly Attractive For Income-Oriented InvestorsSeeking Alpha • 06/22/24
Chimera (CIM) Upgraded to Strong Buy: What Does It Mean for the Stock?Zacks Investment Research • 05/27/24
Chimera Investment Corporation Announces Closing of Public Offering of $65 Million Senior NotesBusiness Wire • 05/22/24
Avilar Therapeutics to Present Preclinical Data for MTAC (M6PR Targeting Chimera) Extracellular Protein Degrader Platform at the American Association of Immunologists Annual MeetingBusiness Wire • 05/01/24
Chimera Investment Corporation Announces Date of First Quarter 2024 Financial Results and Conference CallBusiness Wire • 04/24/24